Over the initial four-week pilot project, the products will be tested on two trolley buses on high-ridership routes and two SkyTrain cars on the Expo and Millennium lines. Two times each week, the surfaces will be swabbed and tested to determine the antimicrobial effectiveness of the products. Upon the conclusion of this pilot project phase, the surfaces will also be examined for durability.
“We’re proud to be the first transit agency in North America to pilot this industry-leading technology and I look forward to working closely with our project partners. We’ve been carefully examining new ways to ensure transit is one of the safest public spaces throughout the pandemic,” said TransLink CEO Kevin Desmond in a statement.
“The risk of COVID-19 transmission on transit remains extremely low and this initiative will only bolster our comprehensive cleaning protocols which are already in place. Any findings from this pilot project will be shared with our fellow transit agency colleagues and other industries which may be able to use this emerging technology.”